Lead-induced alterations of glial fibrillary acidic protein (GFAP) in the developing rat brain

Toxicology and Applied Pharmacology

Volumn 139, Issue 1, 1996, Pages 84-93

  Harry, G Jean ^a   Schmitt, Tamara J ^a,b   Gong, Zhaolong ^c   Brown, Hayes ^a   Zawia, Nasser ^a,d   Evans, Hugh L ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; LEAD; LEAD ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; FETUS; GLIA CELL; MALE; NEUROTOXICITY; NEWBORN; NONHUMAN; PERINATAL PERIOD; RAT;

ANIMALIA;

EID: 0030200726     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0145     Document Type: Article

References (64)

1. Amaducci, L., Forno, K. I., and Eng, L. F. (1981). Glial fibrillary acidic protein in cryogenic lesions of the rat brain. Neurosci. Lett. 21, 27-32.
2. Averill, D., and Needleman, H. (1980). Neonatal lead exposure retards cortical synaptogenesis in the rat. In Low Level Lead Exposure: The Clinical Implications of Current Research (H. Needleman, Ed.), pp. 210-220, Raven Press, New York.
3. Backhovens, H., Gheuens, J., and Slegers, H. (1987). Expression of glial fibrillary acidic protein in rat C6 glioma relates to vimentin and is independent of cell-cell contact. J. Neurochem. 49, 348-354.
4. Bignami, A., and Dahl, D. (1973). Differentiation of astrocytes in the cerebellar cortex and the pyramidal tracts of the newborn rat. An immunofluorescence study with antibodies to a protein specific to astrocytes. Brain Res. 49, 393-402.
5. Bignami, A., and Dahl, D. (1974). Astrocyte-specific protein and neuroglial differentiation. An immunofluorescence study with antibodies to the glial fibrillary acidic protein. J. Comp. Neurol. 153, 27-38.
6. Bignami, A., and Dahl, D. (1976). The astroglial response to stabbing. Immunofluorescence studies with antibodies to astrocyte-specific protein (GFAP) in mammalian and submammalian species. J. Neuropathol. Appl. Neurobiol. 2, 99-110.
7. Bovolenta, P., Liem, R. K. H., and Mason, C. A. (1984). Development of cerebellar astroglia: Transitions in form and cytoskeletal content. Dev. Biol. 102, 248-259.
8. Bovolenta, P., Liem, R. K. H., and Mason, C. A. (1987). Glial filament protein expression in astroglia in the mouse visual pathway. Dev. Brain Res. 33, 113-126.
9. Buchheim, K., Noack, S., Stoltenburg, G., Lilienthal, H., and Winneke, G. (1994). Developmental delay of astrocytes in hippocampus of rhesus monkeys reflects the effect of pre- and postnatal chronic low level lead exposure. Neurotoxicology 15(3), 665-669.
10. Bull, R., McCauley, P., Taylor, D., and Croften, K. (1983). The effects of lead on the developing central nervous system of the rat. Neurotoxicology 4(1), 1-18.
11. Choi, B. H. (1986). Myelin-forming oligodendrocytes of developing mouse spinal cord: Immunocytochemical and ultrastructural studies. J. Neuropathol. Exp. Neurol. 45(5), 513-524.
12. Choi, B. H., and Kim, R. C. (1985). Expression of glial fibrillary acidic protein by immature oligodendroglia and its implications. J. Neuroimmunol. 8, 215-235.
13. Clarkson, T. W. (1987). Metal toxicity in the central nervous system. Environ. Health Perspec. 75, 59-64.
14. Cookman, G., Hemmens, S., Keane, G., King, W., and Regan, C. (1988). Chronic low level lead exposure precociously induces rat glial development in vitro and in vivo. Neurosci. Lett. 86, 33.
15. Dahl, D. (1981). The vimentin-GFA protein transition in rat neuroglia cytoskeleton occurs at the time of myelination. J. Neurosci. Res. 6, 741-748.
16. Dahl, D., Bjorklund, H., and Bignami, A. (1986). Immunological markers in astrocytes. In Astrocytes (S. Fedoroff and A. Vernadakis, Eds.) Vol. 3, pp. 1-25. Academic Press, Toronto.
17. Dave, V., Vitarella, D., Aschner, J. L., Fletcher, P., Kimelberg, H. K., and Aschner, M. (1993). Lead increases inositol 1,4,5-triphosphate levels but does not interfere with calcium transients in primary rat astrocytes. Brain Res. 618, 9-18.
18. Davis, J. M., Otto, D. A., Weil, D. E., and Grant, L. D. (1990). The comparative developmental neurotoxicity of lead in humans and animals. Neurotoxicol. Teratol. 12, 215-229.
19. Egle, P. M., and Skelton, K. R. (1986). Chronic lead intoxication causes brain-specific nuclear protein to accumulate in the nucleii of cells lining kidney tubules. J. Biol. Chem. 261, 2294-2298.
20. Eng, L., Vanderheagen, J., Bignami, A., and Gerstl, B. (1971). An acidic protein isolated from fibrous astrocytes. Brain Res. 28, 351-354.
21. Eng, L. F. (1988). Regulation of glial intermediate filaments in astrogliosis. In Neurology and Neurobiology, Vol. 39: The Biochemical Pathology of Astrocytes, (M. D. Norenberg, L. Hertz, and A. Schousboe, Eds.), pp. 79-90. A. R. Liss, New York.
22. Fedoroff, S. (1986). Prenatal ontogenesis of astrocytes. In Astrocytes (S. Fedoroff, and A. Vernadakis, Eds.), Vol. 3 pp. 35-67. Academic Press, Toronto.
23. Goyer, R. A., and Rhyne, B. C. (1973). Pathological effects of lead. Int. Rev. Exp. Pathol. 12, 1-79.
24. Graeber, M. B., and Krutzberg, G. W. (1986). Astrocytes increase in glial fibrillary acidic protein during retrograde changes of facial motor neurons. J. Neurocytol. 15, 363-373.
25. Hatten, M. E., and Mason, C. A. (1990). Mechanisms of glial-guided neuronal migration in vitro and in vivo. Experientia 46, 907-916.
26. Herpers, M. J., and Budka, H. (1984). Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: Gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol. Berl. 64, 265-272.
27. Holmes, E., Hermanson, G., Cole, R., and DeVellis, J. (1988). Developmental expression of glial-specific mRNAs in primary cultures of rat brain visualized by in situ hybridization. J. Neurosci. Res. 19, 389-396.
28. Holtzman, D., DeVries, C., Nguyen, H., Olson, J., and Bensen, K. (1984). On resistance to lead encephalopathy: Cellular and sub-cellular mechanisms. Neurotoxicology 5, 97-124.
29. Holtzman, D., Olson, J., DeVries, C., and Bensch, K., (1987). Lead toxicity in primary culture cerebral astrocytes and cerebellar granular neurons. Toxicol. and Appl. Pharmacol. 89, 211-225.
30. Jagadha, V., Halliday, W. C., and Becker, L. E. (1986). Glial fibrillary acidic protein (GFAP) in oligodendrogliomas: A reflection of transient GFAP expression by immature oligodendroglia. Can. J. Neurol. Sci. 13(4), 307-311.
31. Kim, S. U., Moretto, G., Shin, D. H., and Lee, V. M. (1985). Modulation of antigenic expression in cultured adult human oligodendrocytes by derivatives of adenosine 3′,5′-cyclic monophosphate. J. Neurol. Sci. 69, 81-91.
32. Kimura, T., Budka, H., and Soler-Federsppiel, S. (1986). An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and s-100 protein (S100P) in human brain tumors. Clin. Neuropathol. 5(1), 21-27.
33. Kretzschmar, H. A., DeArmand, S. J., and Forno, L. S. (1985). Measurement of GFAP in hepatic encephalopathy by ELISA and transblots. J. Neuropathol. Exp. Neurol. 44, 459-471.
34. Krigman, M. R., and Hogan, E. L. (1974). Effect of lead intoxication on the postnatal growth of the rat nervous system. Environ. Health Perspect. May, 187-199.
35. Landry, C. F., Ivy, O., and Brown, I. R. (1990). Developmental expression of glial fibrillary acidic protein mRNA in the rat brain analyzed by in situ hybridization. J. Neurosci. Res. 25, 194-203.
36. Langui, D., Delaunoy, J. P., Ghandour, M. S., and Sensenbrenner, M. (1985). Immunocytochemical demonstration of both carbonic anhydrase isoenzyme II and glial fibrillary acidic protein in some immature rat glial cells in primary culture. Neurosci. Lett. 60(2), 151-156.
37. Lazarides, E. (1982). Intermediate filaments: A chemically heterogeneous, developmentally regulated class of protein. Annu. Rev. Biochem. 51, 219-250.
38. Legare, M. E., Castiglioni, A. J., Jr., Rowles, T. K., Calvin, J. A., Snyder, Armstead, C., and Tiffany-Castiglioni, E. (1993). Morphological alterations of neurons and astrocytes in guinea pigs exposed to low levels of inorganic lead. Neurotoxicology 14(1), 77-80.
39. Levitt, P., and Rakic, P. (1980). Immunoperoxidase localization of GFAP in radial glial cells and astrocytes of developing Rhesus monkey brain. J. Comp. Neurol. 193, 815-840.
40. Lewis, S. A., and Cowan, N. J. (1985). Temporal expression of mouse glial fibrillary acidic protein mRNA studied by a rapid in situ hybridization procedure. J. Neurochem. 45, 913-919.
41. Li, X., and Bartlett, W. P. (1991). Developmental expression of glial fibrillary acidic protein and glutamine synthetase mRNAs in normal and jimpy mice. Mol. Brain Res. 9, 313-317.
42. Maniatis, T., Fritsch, E., and Sambrook, J. (1989). Extraction, purification, and analysis of mRNA from eukaryotic cells. In Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
43. McCauley, P., Bull, R., Tonti, P., Lutkenhoff, S., Meister, M., and Doerger Stober, J. (1982). The effect of prenatal and postnatal lead exposure on neonatal synaptogenesis in the rat cerebral cortex, J. Toxicol. Environ. Health. 10, 639-651.
44. Miller, R. (1966). Simultaneous Statistical Inference. McGraw-Hill, New York.
45. Moore, J. E., and Goyer, R. A. (1974). Lead-induced inclusion bodies: Composition and probable role in lead metabolism. Environ. Health Perspect. 7, 121-127.
46. Naus, C. C. G., and Bechberger, J. F. (1991). Effect of prenatal ethanol exposure on postnatal neural gene expression in the rat. Dev. Genet. 12, 293-298.
47. O'Callaghan, J. P. (1991). Quantification of glial fibrillary acidic protein: Comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13, 275-281.
48. Ogawa, H., Sato, Y., Takeshita, I., Tateishi, J., and Kitamura, K. (1985). Transient expression of glial fibrillary acidic protein in developing oligodendrocytes in vitro. Brain Res. 350, 133-141.
49. Petit, T., and LeBoutillier, J. (1979). Effects of lead exposure during development on neocortical dendritic and synaptic structure. Exp. Neurol. 64, 482-492.
50. Petit, T., Alfano, D., and LeBoutillier, J. (1983). Early lead exposure and the hippocampus: A review and recent advances. Neurotoxicology 4(1), 79-94.
51. Raff, M. C., Abney, E. A., and Miller, A. (1984). Two glial cell lineages diverge prenatally in rat optic nerve. Dev. Biol. 106, 53-60.
52. Rakic, P. (1981). Neuron-glial interaction during brain development. Trends Neurosci. 4, 184-187.
53. Selvin-Testa, A., Lopez-Costa, J. J., Nessi de Avinon, A. C., and Saavedra J. P. (1991). Astroglial alterations in rat hippocampus during chronic lead exposure. Glia, 384-392.
54. Shafit-Zagardo, B., Peterson, C., and Goldman, J. E. (1988). Rapid increases in glial fibrillary acidic protein mRNA and protein levels in the copper-deficient brindled mouse. J. Neurochem. 51, 1258-1266.
55. Steinert, P., and Roop, D. (1988). Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem. 57, 593-625.
56. Sundstrom, R., and Kalimo, H. (1987). Extracellular edema and glial response in the cerebellum of suckling rats with low-dose lead encephalopathy. Acta Neuropathol. 75, 116-122.
57. Tardy, M., Fages, C., Riol, H., LePrince, G., Rataboul, P., Charriere-Bertrand, D., and Nunez, J. (1989). Developmental expression of the glial fibrillary acidic protein mRNA in the central nervous system and in cultured astrocytes. J. Neurochem. 52, 162-167.
58. Tardy, M., Fages, C., Le Prince, G., Rolland, B., and Nunez, J. (1990). Regulation of the glial fibrillary acidic protein (GFAP) and of its encoding mRNA in the developing brain and in cultured astrocytes. In Mol. Asp. Develop. and Aging, pp. 41-52, Plenum, New York.
59. Tiffany-Castiglioni, E., Sierra, E., Wu, J., and Rowles, T. (1989). Lead toxicity in neuroglia. Neurotoxicology. 10, 417-444.
60. Tsuneishi, S., Takada, S., Motoike, T., Ohashi, T., Sano, K., and Nakamura, H. (1991). Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein genes in developing rat brain. Dev. Brain Res. 61, 117-123.
61. Valentino, K. L., Jones, E. F., and Kane, S. A. (1983). Expression of GFAP immunoreactivity during development of long fiber tracts in the rat CNS. Dev. Brain Res. 9, 319-336.
62. Verebey, K., Eng, Y. M., Davidow, B., and Ramon, A. (1991). Rapid, sensitive micro blood lead analysis: A mass screening technique for lead poisoning. J. Anal. Toxicol. 15(5), 237-240.
63. Verebey, K., Rosen, J. F., Schonfeld, D. J., Carriero, D., Eng, Y. M., Deutsch, J., Reimer, S., and Hogan, J. (1995). Blood collection and analytical considerations in blood lead screening in children. Clin. Chem. 41, 469-470.
64. Widzowski, D. V., Finkelstein, J. N., Pokora M. J., and Cory-Slechta, D. A. (1994). Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity. Neurotoxicology 15, 853-866.